Motco Biogen Inc. Transaction History

Motco

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$212.02 - $267.71 $46,432 - $58,628	219 Added 21900.0%	220 $47,000
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $15,803 - $19,023	-71 Reduced 98.61%	1 $0
Q3 2023 Nov 07, 2023	SELL	$253.3 - $285.89 $253 - $285	-1 Reduced 1.37%	72 $18,000
Q2 2023 Aug 04, 2023	BUY	$275.25 - $318.06 $550 - $636	2 Added 2.82%	73 $20,000
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $17,923 - $21,777	71 New	71 $19,000
Q1 2021 Apr 16, 2021	SELL	$242.95 - $284.63 $3,887 - $4,554	-16 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $4,301 - $5,456	16 New	16 $5,000
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $14,133 - $15,852	-65 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $14,253 - $15,711	65 New	65 $15,000
Q3 2017 Nov 07, 2017	SELL	$281.15 - $329.69 $5,904 - $6,923	-21 Closed	0 $0
Q2 2017 Aug 08, 2017	BUY	N/A	21	21 $6,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Motco, based on Form 13F filings with the SEC.

Stay updated on Motco with notifications on news.